Clinical trial

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

NCT07116889

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-12-12

PhasePHASE1

Study timeline

Study start (actual)2023-12-12Date precision: day

Registry last updated2025-11-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

COPD (Chronic Obstructive Pulmonary Disease)unresolved

Interventions

GB-0895 (SC)BIOLOGICAL

Placebo (SC)DRUG

Sponsors & collaborators

Generate Biomedicineslead sponsor

Mapped research locations

LondonUnited Kingdom2 MiamiFlorida, United States1 BerlinGermany1 OrlandoFlorida, United States1 Winston-SalemNorth Carolina, United States1 ManchesterUnited Kingdom1 HanoverGermany1 FrankfurtGermany1 Saint PaulMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07116889 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.